—Researchers explored the relationship between renin-angiotensin-aldosterone system inhibitors and hyperkalemia in boosting the risk of all-cause or cardiovascular death in patients with heart failure ...
Hyperkalemia is a potentially life-threatening side effect of RAASi use. Individuals with heart failure are particularly susceptible because heart failure itself can cause hyperkalemia. “Several ...
A real-world study finds reduced RAASi-related hyperkalemia risk among at-risk patients initiating SGLT2 inhibitors. Sodium glucose cotransporter 2 inhibitor (SGLT2i) use is associated with lower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback